Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8653551 | Annals of Vascular Surgery | 2018 | 27 Pages |
Abstract
ARREST will be pivotal in assessing the safety of MSC infusion and provide preliminary data on the ability of MSCs to favorably modulate the pathogenic AAA host immune response. The data gleaned from this phase I trial will provide the groundwork for a larger, phase III RCT which may provide the first pharmaceutical intervention for AAA.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
S. Keisin Wang, Linden A. Green, Ashley R. Gutwein, Natalie A. Drucker, Raghu L. Motaganahalli, Andres Fajardo, Clifford M. Babbey, Michael P. Murphy,